Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,202
Closed -$2.17M – 520
2026
Q1
$2.17M Buy
+12,202
New +$1.92M 0.88% 10
2019
Q4
– Sell
-9,741
Closed -$1.45M – 1950
2019
Q3
$1.45M Sell
9,741
-13,202
-58% -$2.01M 0.03% 731
2019
Q2
$3.41M Sell
22,943
-11,941
-34% -$1.64M 0.07% 398
2019
Q1
$4.82M Buy
34,884
+9,717
+39% +$1.22M 0.11% 219
2018
Q4
$2.7M Buy
25,167
+4,487
+22% +$500K 0.07% 336
2018
Q3
$2.56M Sell
20,680
-11,974
-37% -$1.33M 0.05% 527
2018
Q2
$3.22M Buy
32,654
+13,880
+74% +$1.32M 0.06% 381
2018
Q1
$1.65M Sell
18,774
-11,554
-38% -$1.01M 0.03% 682
2017
Q4
$2.6M Buy
30,328
+12,372
+69% +$1.07M 0.06% 451
2017
Q3
$1.55M Buy
17,956
+11,847
+194% +$1.05M 0.03% 745
2017
Q2
$557K Sell
6,109
-46,040
-88% -$4.23M 0.01% 1071
2017
Q1
$4.86M Buy
52,149
+30,117
+137% +$2.48M 0.12% 153
2016
Q4
$1.49M Sell
22,032
-31,579
-59% -$1.94M 0.05% 396
2016
Q3
$3.19M Sell
53,611
-83,090
-61% -$4.69M 0.1% 282
2016
Q2
$7.18M Buy
136,701
+48,089
+54% +$2.26M 0.24% 92
2016
Q1
$3.71M Buy
88,612
+78,592
+784% +$2.96M 0.11% 242
2015
Q4
$424K Buy
+10,020
New +$409K 0.01% 700

Other funds holding MASI

Oxford Asset Management's MASI Position: Q2 2026 in Review

Oxford Asset Management sold out of Masimo (MASI) in Q2 2026, closing a stake of 12,202 shares — an estimated $2.17M sold.

Oxford Asset Management first reported a position in MASI in Q4 2015 and held it in 17 quarters. The position peaked at $7.18M in Q2 2016. 2 funds tracked by Wall St. Rank hold MASI as of Q2 2026.

  • Oxford Asset Management reported no remaining Masimo position as of Q2 2026 after selling out during the quarter.
  • Oxford Asset Management sold 12,202 Masimo shares in Q2 2026, an estimated $2.17M.
  • Oxford Asset Management first reported a position in Masimo in Q4 2015 and held it in 17 quarters.
  • Oxford Asset Management's Masimo position peaked at $7.18M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Masimo as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.